Pharmacist-led medication non-adherence intervention: reducing the economic burden placed on the Australian health care system
Rachelle Louise Cutler,1 Andrea Torres-Robles,1 Elyssa Wiecek,1 Barry Drake,2 Naomi Van der Linden,3 Shalom I (Charlie) Benrimoj,4 Victoria Garcia-Cardenas11Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; 2Faculty of Engineering and Information Technology, Univers...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2019-05-01
|
| Series: | Patient Preference and Adherence |
| Subjects: | |
| Online Access: | https://www.dovepress.com/pharmacist-led-medication-non-adherence-intervention-reducing-the-econ-peer-reviewed-article-PPA |
| _version_ | 1819047885513162752 |
|---|---|
| author | Cutler RL Torres-Robles A Wiecek E Drake B Van der Linden N Benrimoj SI Garcia-Cardenas V |
| author_facet | Cutler RL Torres-Robles A Wiecek E Drake B Van der Linden N Benrimoj SI Garcia-Cardenas V |
| author_sort | Cutler RL |
| collection | DOAJ |
| description | Rachelle Louise Cutler,1 Andrea Torres-Robles,1 Elyssa Wiecek,1 Barry Drake,2 Naomi Van der Linden,3 Shalom I (Charlie) Benrimoj,4 Victoria Garcia-Cardenas11Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; 2Faculty of Engineering and Information Technology, University of Technology Sydney, Sydney, NSW, Australia; 3AstraZeneca Netherlands, The Hauge, Netherlands; 4Sydney University, Sydney, NSW, AustraliaBackground: Scarcity of prospective medication non-adherence cost measurements for the Australian population with no directly measured estimates makes determining the burden medication non-adherence places on the Australian health care system difficult. This study aims to indirectly estimate the national cost of medication non-adherence in Australia comparing the cost prior to and following a community pharmacy-led intervention.Methods: Retrospective observational study. A de-identified database of dispensing data from 20,335 patients (n=11,257 on rosuvastatin, n=6,797 on irbesartan and n=2,281 on desvenlafaxine) was analyzed and average adherence rate determined through calculation of PDC. Included patients received a pharmacist-led medication adherence intervention and had twelve months dispensing records; six months before and six months after the intervention. The national cost estimate of medication non-adherence in hypertension, dyslipidemia and depression pre- and post-intervention was determined through utilization of disease prevalence and comorbidity, non-adherence rates and per patient disease-specific adherence-related costs.Results: The total national cost of medication non-adherence across three prevalent conditions, hypertension, dyslipidemia and depression was $10.4 billion equating to $517 per adult. Following enrollment in the pharmacist-led intervention medication non-adherence costs per adult decreased $95 saving the Australian health care system and patients $1.9 billion annually.Conclusion: In the absence of a directly measured national cost of medication non-adherence, this estimate demonstrates that pharmacists are ideally placed to improve patient adherence and reduce financial burden placed on the health care system due to non-adherence. Funding of medication adherence programs should be considered by policy and decision makers to ease the current burden and improve patient health outcomes moving forward.Keywords: medication adherence, community pharmacy, big data, dispensing records, health economics |
| first_indexed | 2024-12-21T11:07:28Z |
| format | Article |
| id | doaj.art-a3eadddcc7cd48b080b1dadccc8c4b15 |
| institution | Directory Open Access Journal |
| issn | 1177-889X |
| language | English |
| last_indexed | 2024-12-21T11:07:28Z |
| publishDate | 2019-05-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Patient Preference and Adherence |
| spelling | doaj.art-a3eadddcc7cd48b080b1dadccc8c4b152022-12-21T19:06:11ZengDove Medical PressPatient Preference and Adherence1177-889X2019-05-01Volume 1385386245991Pharmacist-led medication non-adherence intervention: reducing the economic burden placed on the Australian health care systemCutler RLTorres-Robles AWiecek EDrake BVan der Linden NBenrimoj SIGarcia-Cardenas VRachelle Louise Cutler,1 Andrea Torres-Robles,1 Elyssa Wiecek,1 Barry Drake,2 Naomi Van der Linden,3 Shalom I (Charlie) Benrimoj,4 Victoria Garcia-Cardenas11Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; 2Faculty of Engineering and Information Technology, University of Technology Sydney, Sydney, NSW, Australia; 3AstraZeneca Netherlands, The Hauge, Netherlands; 4Sydney University, Sydney, NSW, AustraliaBackground: Scarcity of prospective medication non-adherence cost measurements for the Australian population with no directly measured estimates makes determining the burden medication non-adherence places on the Australian health care system difficult. This study aims to indirectly estimate the national cost of medication non-adherence in Australia comparing the cost prior to and following a community pharmacy-led intervention.Methods: Retrospective observational study. A de-identified database of dispensing data from 20,335 patients (n=11,257 on rosuvastatin, n=6,797 on irbesartan and n=2,281 on desvenlafaxine) was analyzed and average adherence rate determined through calculation of PDC. Included patients received a pharmacist-led medication adherence intervention and had twelve months dispensing records; six months before and six months after the intervention. The national cost estimate of medication non-adherence in hypertension, dyslipidemia and depression pre- and post-intervention was determined through utilization of disease prevalence and comorbidity, non-adherence rates and per patient disease-specific adherence-related costs.Results: The total national cost of medication non-adherence across three prevalent conditions, hypertension, dyslipidemia and depression was $10.4 billion equating to $517 per adult. Following enrollment in the pharmacist-led intervention medication non-adherence costs per adult decreased $95 saving the Australian health care system and patients $1.9 billion annually.Conclusion: In the absence of a directly measured national cost of medication non-adherence, this estimate demonstrates that pharmacists are ideally placed to improve patient adherence and reduce financial burden placed on the health care system due to non-adherence. Funding of medication adherence programs should be considered by policy and decision makers to ease the current burden and improve patient health outcomes moving forward.Keywords: medication adherence, community pharmacy, big data, dispensing records, health economicshttps://www.dovepress.com/pharmacist-led-medication-non-adherence-intervention-reducing-the-econ-peer-reviewed-article-PPAmedication adherencecommunity pharmacybig datadispensing recordshealth economics |
| spellingShingle | Cutler RL Torres-Robles A Wiecek E Drake B Van der Linden N Benrimoj SI Garcia-Cardenas V Pharmacist-led medication non-adherence intervention: reducing the economic burden placed on the Australian health care system Patient Preference and Adherence medication adherence community pharmacy big data dispensing records health economics |
| title | Pharmacist-led medication non-adherence intervention: reducing the economic burden placed on the Australian health care system |
| title_full | Pharmacist-led medication non-adherence intervention: reducing the economic burden placed on the Australian health care system |
| title_fullStr | Pharmacist-led medication non-adherence intervention: reducing the economic burden placed on the Australian health care system |
| title_full_unstemmed | Pharmacist-led medication non-adherence intervention: reducing the economic burden placed on the Australian health care system |
| title_short | Pharmacist-led medication non-adherence intervention: reducing the economic burden placed on the Australian health care system |
| title_sort | pharmacist led medication non adherence intervention reducing the economic burden placed on the australian health care system |
| topic | medication adherence community pharmacy big data dispensing records health economics |
| url | https://www.dovepress.com/pharmacist-led-medication-non-adherence-intervention-reducing-the-econ-peer-reviewed-article-PPA |
| work_keys_str_mv | AT cutlerrl pharmacistledmedicationnonadherenceinterventionreducingtheeconomicburdenplacedontheaustralianhealthcaresystem AT torresroblesa pharmacistledmedicationnonadherenceinterventionreducingtheeconomicburdenplacedontheaustralianhealthcaresystem AT wieceke pharmacistledmedicationnonadherenceinterventionreducingtheeconomicburdenplacedontheaustralianhealthcaresystem AT drakeb pharmacistledmedicationnonadherenceinterventionreducingtheeconomicburdenplacedontheaustralianhealthcaresystem AT vanderlindenn pharmacistledmedicationnonadherenceinterventionreducingtheeconomicburdenplacedontheaustralianhealthcaresystem AT benrimojsi pharmacistledmedicationnonadherenceinterventionreducingtheeconomicburdenplacedontheaustralianhealthcaresystem AT garciacardenasv pharmacistledmedicationnonadherenceinterventionreducingtheeconomicburdenplacedontheaustralianhealthcaresystem |